Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Hologic Inc | HOLX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
77.19 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 64.02 - 87.88 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 77.19 | USD |
Hologic (HOLX) Options Flow Summary
Hologic Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
18.12B | 234.73M | - | 4.05B | 456M | 1.94 | 39.74 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Hologic News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HOLX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 75.28 | 77.81 | 74.53 | 75.76 | 1,536,556 | 1.91 | 2.54% |
1 Month | 76.60 | 79.22 | 74.53 | 76.87 | 1,564,256 | 0.59 | 0.77% |
3 Months | 75.05 | 79.22 | 71.25 | 75.29 | 1,804,155 | 2.14 | 2.85% |
6 Months | 67.17 | 79.22 | 64.02 | 72.85 | 1,827,608 | 10.02 | 14.92% |
1 Year | 84.19 | 87.88 | 64.02 | 74.65 | 1,746,874 | -7.00 | -8.31% |
3 Years | 73.31 | 87.88 | 59.78 | 73.11 | 1,753,778 | 3.88 | 5.29% |
5 Years | 43.89 | 87.88 | 26.49 | 65.54 | 1,896,751 | 33.30 | 75.87% |
Hologic Description
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (64% of total sales, boosted by pandemic), breast health (21% of sales, suppressed by pandemic), surgical (12%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (75%), followed by Europe (16%), Asia (6%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts. |